Atrial fibrillation in elderly patients with dementia

Gerontology

Volumn 55, Issue 2, 2009, Pages 202-204

  Formiga, Francesc ^a   Fort, Isabel ^b   Reig, Lluis ^c   Robles, Maria Jose ^d   Espinosa, Maria Carmen ^e   Rodriguez, Daniel ^f  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b Alzheimer's Disease and Other Dementias Integral Care Unit   (Spain)

^c Integral Health Consortium   (Spain)

^d HOSPITAL DE L ESPERANÇA   (Spain)

^e Maresme Health Consortium   (Spain)

^f Integral Outpatient Cognitive Disorder Evaluation Service   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; ANTICOAGULANT AGENT; WARFARIN;

AGED; AGING; ALZHEIMER DISEASE; ANTICOAGULANT THERAPY; BARTHEL INDEX; COMORBIDITY; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DEMENTIA; DRUG USE; FEMALE; FUNCTIONAL ASSESSMENT; GERIATRIC PATIENT; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MULTIINFARCT DEMENTIA; PRIORITY JOURNAL; THROMBOEMBOLISM; TREATMENT INDICATION;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; DEMENTIA; FEMALE; HUMANS; MALE; PLATELET AGGREGATION INHIBITORS; RISK FACTORS; SPAIN; WARFARIN;

EID: 62249084645     PISSN: 0304324X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000155654     Document Type: Letter

References (20)

1. Jorm AF, Korten AE, Henderson AS: The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr Scand 1987;76:465-479.
2. Furberg CD, Psaty BM, Manolio TA, Gardin JM, Smith VE, Rautaharju PM: Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol 1994;74:236-241.
3. Fuster V, Ryden LE, Cannom DS, et al: ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation - Executive Summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006;114:e257-e354.
4. McCrory DC, Matchar DB, Samsa G, Sanders LL, Pritchett EL: Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly. Arch Intern Med 1995;155:277-281.
5. Moroney JT, Tseng CL, Paik MC, Mohr JP, Desmond DW: Treatment for the secondary prevention of stroke in older patients: the influence of dementia status. J Am Geriatr Soc 1999;47:824-829.
6. Formiga F, Fort I, Robles MJ, Barranco E, Espinosa MC, Riu S: Comorbilidad en pacientes ancianos con demencia. Diferencias por edad y genero. Rev Clin Esp 2007;207:495-500.
7. Formiga F, Fort I, Robles MJ, Riu S, Rodríguez D, Sabartes O: Aspectos diferenciales de comorbilidad en pacientes ancianos con demencia tipo Alzheimer o con demencia vascular. Rev Neurol 2008;46:72-76.
8. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, APA, 1993.
9. Reisberg B: Functional Assessment Staging (FAST). Psychopharmacol Bull 1988;24:653-659.
10. Mahoney FI, Barthel DW: Functional evaluation: the Barthel Index. A simple index of independence useful in scoring improvement in the rehabilitation of the chronically ill. Md State Med J 1965;14:61-65.
11. Lawton MP, Brody EM: Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969;9:179-186.
12. Folstein MF, Folstein SE, McHugh PR: 'Mini mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
13. Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-383.
14. Ott A, Breteler MM, de Bruyne MC, van Harskamp F, Grobbee DE, Hofman A: Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. Stroke 1997;28:316-321.
15. De Ferrari GM, Klersy C, Ferrero P, Fantoni C, Salerno-Uriarte D, Manca L, Devecchi P, Molon G, Revera M, Curnis A, Sarzi Braga S, Accardi F, Salerno-Uriarte JA; ALPHA Study Group: Atrial fibrillation in heart failure patients: prevalence in daily practice and effect on the severity of symptoms. Data from the ALPHA study registry. Eur J Heart Fail 2007;9:502-509.
16. Barber M, Tait RC, Scott J, Rumley A, Lowe GD, Stott DJ: Dementia in subjects with atrial fibrillation: hemostatic function and the role of anticoagulation. J Thromb Haemost 2004;2:1873-1878.
17. Go AS, Hylek EM, Chang Y, Phillips KA, Henault LE, Capra AM, Jensvold NG, Selby JV, Singer DE: Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? JAMA 2003;290:2685-2692.
18. Ingelgard A, Hollowell J, Prabashni R, Gold K, Tran K, Fitzmaurice D: What are the barriers to warfarin use in atrial fibrillation? Development of a questionnaire. J Thromb Thrombolysis 2006;21:257-265.
19. Van Deelen BA, van den Bemt PM, Egberts TC, van't Hoff A, Mass HA: Cognitive impairment as determinant for suboptimal control of anticoagulation treatment in elderly patients with atrial fibrillation. Drugs Aging 2005;22:353-360.
20. Stollberger C, Winkler-Dworak M, Finsterer J, Hartl E, Chnupa P: Factors influencing mortality in atrial fibrillation. Post-hoc analysis of an observational study in outpatients. Int J Cardiol 2005;103:140-144.